On July 6, 2017, Zur Rose Group AG, the leading "pure play" e-commerce pharmacy in Europe, completed its initial public offering (IPO) and listing on SIX Swiss Exchange (ticker symbol ROSE, ISIN CH0042615283). The total placement volume was CHF 252 m and the book was multiple times oversubscribed at the offer price of CHF 140, which was the high end of the price range. The bank syndicate comprised UBS and Berenberg as Joint Global Coordinators and Joint Bookrunners, and Zürcher Kantonalbank as Co-Lead Manager.

Homburger acted as issuer counsel to Zur Rose Group AG. The Homburger IPO team was led by partner Dieter Gericke (Corporate | M&A) and comprised partner Reto Heuberger (Tax), associates Daniel Häusermann (Corporate | M&A), Vanessa Isler (Financial Services), Luca Dal Molin (IP | IT) and Ralf Imstepf (Tax), as well as junior associates Philippe Baumann and Manuel Baschung. Georg Rauber advised on the transaction and related workstreams as client relationship partner.